Contact Cell Machines

Name *


Cell Machines, Inc.
11222 Richmond Ave, Suite 180
Houston, TX 77082

James H. Kelly, PhD
President, CEO and Chief Scientific Officer


Cell Machines, Inc., is a biotechnology company employing high efficiency biology and bioprocessing to produce long half life Factor VIII and Factor IX, dramatically reducing the cost and difficulty of treatment in the $11 billion hemophilia market. Our long half life version of factor VIII, Stabile8, utilizes completely new technology to stabilize the protein and extend its half life and can be applied to existing factor VIII. This is combined with a high efficiency human liver cell based production system that can utilize a mobile clean room based facility. Together, these innovations can dramatically reduce the cost of treatment in the developed world and deliver therapy to the 75% of hemophilia patients who are untreated worldwide.